Dermatologic toxicity associated with targeted and immunotherapies in stage-IV non-small cell lung cancer patients: A 14-year cohort

J Am Acad Dermatol. 2024 Jul;91(1):172-175. doi: 10.1016/j.jaad.2024.03.029. Epub 2024 Mar 29.
No abstract available

Keywords: dermatologic toxicity; immunotherapy; lung cancer; survival; targeted therapy.

Publication types

  • Letter

MeSH terms

  • Aged
  • Carcinoma, Non-Small-Cell Lung* / drug therapy
  • Carcinoma, Non-Small-Cell Lung* / therapy
  • Cohort Studies
  • Drug Eruptions / etiology
  • Female
  • Humans
  • Immune Checkpoint Inhibitors / adverse effects
  • Immunotherapy / adverse effects
  • Immunotherapy / methods
  • Lung Neoplasms* / drug therapy
  • Lung Neoplasms* / therapy
  • Male
  • Middle Aged
  • Molecular Targeted Therapy / adverse effects
  • Neoplasm Staging*
  • Retrospective Studies

Substances

  • Immune Checkpoint Inhibitors